About Paratus Clinical Research Canberra
Clinical Trials at Paratus Clinical Research Canberra
During the past decade, Paratus Clinical Research Canberra conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Paratus Clinical Research Canberra" #1 sponsor was "Novavax" with 3 trials, followed by "Actinogen Medical" with 1 trials
sponsored, "Cerecin" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Enanta Pharmaceuticals, Inc"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Paratus Clinical Research Canberra"
#1 collaborator was "Avance Clinical" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Paratus Clinical Research Canberra
According to Clinical.Site data, the most researched conditions in "Paratus Clinical Research Canberra" are
"COVID-19" (2 trials), "Respiratory Syncytial Virus" (2 trials), "Alzheimer's Disease" (1 trials), "Covid19" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Paratus Clinical Research Canberra" in a lesser frequency.
Clinical Trials Intervention Types at Paratus Clinical Research Canberra
Most popular intervention types in "Paratus Clinical Research Canberra" are "Drug" (7 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "CIC Vaccine" (1 trials), "EDP-938" (1 trials), "ICC Vaccine" (1 trials) and "Influenza Vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Paratus Clinical Research Canberra
The vast majority of trials in "Paratus Clinical Research Canberra" are
10 trials for "All" genders.
Clinical Trials Status at Paratus Clinical Research Canberra
Currently, there are NaN active trials in "Paratus Clinical Research Canberra".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in Paratus Clinical Research Canberra,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Paratus Clinical Research Canberra, 2 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".